The FDA has approved Zepatier for the treatment of HCV genotypes 1 and 4 infections. Zepatier has been approved by the FDA to treat hepatitis C virus genotypes 1 and 4 infections in adult patients.
Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...
WATERTOWN, Mass.,--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a chemistry-driven biotechnology company dedicated to creating and developing small molecule drugs for viral infections ...
Sovaldi (sofosbuvir) is a prescription drug that’s used to treat hepatitis C. Sovaldi comes in the form of tablets and pellets, both of which you take by swallowing. Sovaldi is prescribed to adults ...
Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...
Scientists have discovered a 'switch' in the Hepatitis C virus which could be used as a target for new kinds of drug treatment. Hepatitis C affects more than 170 million people worldwide, but current ...
Hepatitis C is a serious blood borne disease that can cause severe liver damage and impacts over 2.5 million Americans. While the disease can be treated, treatment is not yet universally available and ...
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results